Literature DB >> 31741672

Vitamin D and Selenium in a Thyroid Eye Disease Population in Texas.

Ama Sadaka1, Kimberly Nguyen2, Amina Malik1, Rosbel Brito1, Shauna Berry1, Andrew G Lee1,2,3,4,5,6.   

Abstract

There is growing evidence of thyroid eye disease association with nutritional deficiencies including selenium and vitamin D. We conducted a retrospective chart review of all patients with clinical diagnosis of TED seen at our clinic from 2016 to 2017. Thirty-five patients met inclusion criteria and had serum 25-hydroxyvitamin D levels available, and 19 had selenium levels available. 7/35 (20%) patients had vitamin D deficiency, and 11 (31%) had vitamin D insufficiency, but none had selenium deficiency. Although both selenium and vitamin D supplementation have been recommended for TED, further investigation is necessary to justify supplementation for patients with TED.
© 2019 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Thyroid eye disease; selenium deficiency; vitamin D deficiency

Year:  2019        PMID: 31741672      PMCID: PMC6844498          DOI: 10.1080/01658107.2019.1566382

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  18 in total

Review 1.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

2.  Effect of Selenium Supplementation on Recurrent Hyperthyroidism Caused by Graves' Disease: A Prospective Pilot Study.

Authors:  L Wang; B Wang; S R Chen; X Hou; X F Wang; S H Zhao; J Q Song; Y G Wang
Journal:  Horm Metab Res       Date:  2016-07-08       Impact factor: 2.936

3.  Prevalence and correlates of vitamin D deficiency in US adults.

Authors:  Kimberly Y Z Forrest; Wendy L Stuhldreher
Journal:  Nutr Res       Date:  2011-01       Impact factor: 3.315

Review 4.  Multiple Nutritional Factors and the Risk of Hashimoto's Thyroiditis.

Authors:  Shiqian Hu; Margaret P Rayman
Journal:  Thyroid       Date:  2017-04-06       Impact factor: 6.568

5.  Selenium and the course of mild Graves' orbitopathy.

Authors:  Claudio Marcocci; George J Kahaly; Gerasimos E Krassas; Luigi Bartalena; Mark Prummel; Matthias Stahl; Maria Antonietta Altea; Marco Nardi; Susanne Pitz; Kostas Boboridis; Paolo Sivelli; George von Arx; Maarten P Mourits; Lelio Baldeschi; Walter Bencivelli; Wilmar Wiersinga
Journal:  N Engl J Med       Date:  2011-05-19       Impact factor: 91.245

6.  Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells.

Authors:  E Borgogni; E Sarchielli; M Sottili; V Santarlasci; L Cosmi; S Gelmini; A Lombardi; G Cantini; G Perigli; M Luconi; G B Vannelli; F Annunziato; L Adorini; M Serio; C Crescioli
Journal:  Endocrinology       Date:  2008-03-27       Impact factor: 4.736

Review 7.  Selenium and Thyroid Disease: From Pathophysiology to Treatment.

Authors:  Mara Ventura; Miguel Melo; Francisco Carrilho
Journal:  Int J Endocrinol       Date:  2017-01-31       Impact factor: 3.257

8.  Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.

Authors:  Nan Xia; Xiaozhen Ye; Xiaohao Hu; Shiyu Song; Hui Xu; Mengyuan Niu; Hongwei Wang; Jian Wang
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

9.  Association of vitamin D status and clinical and radiological outcomes in a treated MS population in Poland.

Authors:  Sławomir Wawrzyniak; Emilia Mikołajewska; Ewelina Kuczko-Piekarska; Anna Niezgodzińska-Maciejek; Aleksander Goch
Journal:  Brain Behav       Date:  2016-12-07       Impact factor: 2.708

10.  Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.

Authors:  Torquil Watt; Per Cramon; Jakob Bue Bjorner; Steen Joop Bonnema; Ulla Feldt-Rasmussen; Christian Gluud; Jeppe Gram; Jane Lindschou Hansen; Laszlo Hegedüs; Nils Knudsen; Pernille Bach-Mortensen; Runa Nolsøe; Birte Nygaard; Flemming Pociot; Maria Skoog; Per Winkel; Ase Krogh Rasmussen
Journal:  Trials       Date:  2013-04-30       Impact factor: 2.279

View more
  4 in total

Review 1.  Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.

Authors:  Vardaan Gupta; Christine L Hammond; Elisa Roztocil; Mithra O Gonzalez; Steven E Feldon; Collynn F Woeller
Journal:  Surv Ophthalmol       Date:  2021-09-04       Impact factor: 6.197

Review 2.  Vitamin D, the Vitamin D Receptor, Calcitriol Analogues and Their Link with Ocular Diseases.

Authors:  Miłosz Caban; Urszula Lewandowska
Journal:  Nutrients       Date:  2022-06-05       Impact factor: 6.706

Review 3.  Vitamin D and Ocular Diseases: A Systematic Review.

Authors:  Hei-Nga Chan; Xiu-Juan Zhang; Xiang-Tian Ling; Christine Huyen-Trang Bui; Yu-Meng Wang; Patrick Ip; Wai-Kit Chu; Li-Jia Chen; Clement C Tham; Jason C Yam; Chi-Pui Pang
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

Review 4.  Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.

Authors:  Caroline Y Yu; Rebecca L Ford; Sara T Wester; Erin M Shriver
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.